Repligen Corp

RGEN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$683.00LszswjMqmwrqlwx

Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier

Business Strategy and Outlook

Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems for both upstream and downstream processes, prepacked chromatography columns, proteins used in chromatography resins, and process analytic systems. Although Repligen is a relatively small player, we believe it is at the forefront of the innovation frontier. In the past 10 years, it has transformed from a company mostly known for its protein A ligands to one with a track record of launching new products with limited or no direct competition.

Sponsor Center